Biotech · Private company · Seattle, WA, US
Aurion Biotech, Inc.
SEC CIK 0001924356
Track this companyFree. Adds Aurion Biotech, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Combination Product: AURN001 + Y-27632Phase 3 · Corneal EdemaClinicalTrials.gov · fetched Nov 12, 2026
- AURN001Phase 2 · Corneal EdemaClinicalTrials.gov · fetched Nov 12, 2026
- Corneal Endothelial CellsPhase 2 · Corneal EdemaClinicalTrials.gov · fetched Nov 12, 2026
- Y27632Phase 2 · Corneal EdemaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial DysfunctionPHASE3 · ACTIVE_NOT_RECRUITING · started Feb 19, 2026ClinicalTrials.gov NCT07368959 · fetched Nov 12, 2026
- A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)PHASE1_PHASE2 · COMPLETED · started Oct 18, 2023ClinicalTrials.gov NCT06041256 · fetched Nov 12, 2026